APA Not on Board With ‘Physician Associate’; COVID’s Immune-Mediated Depression

The American Psychiatric Association (APA) released a statement against the American Academy of PAs’ decision to rebrand their profession by changing the title of physician assistant to physician associate; the APA said it would increase patient confusion.

Natural early birds were less likely to experience depressive symptoms compared with night owls. (Molecular Psychiatry)

Another symptom COVID long-haulers may face: immune-mediated depression. (Forbes)

Obsessive-compulsive disorder may be under-represented as a primary diagnosis, according to an analysis of commercial healthcare claims presented at the Going Digital: Behavioral Health Tech conference.

Not surprisingly, more than half of transgender or gender minority adolescents between the ages of 13 and 17 said they use substances as a way to cope with stress. (PLOS One)

A psychiatrist from New York City was lampooned after sharing fantasies of shooting white people in the head during a talk at Yale University, although she said she was only using “provocation as a tool for real engagement.” (New York Times)

A pooled analysis of three clinical trials found that 42 mg of lumateperone (Caplyta) for schizophrenia was both safe and tolerable, showing a similar metabolic profile compared with placebo, Intra-Cellular Therapies announced.

Maine is facing a psychiatrist shortage, due to its aging population and not enough young people entering the field. (Bangor Daily News)